These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25248754)

  • 61. LGE Means Better Selection of HCM Patients for Primary Prevention Implantable Defibrillators.
    Maron BJ; Maron MS
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1403-1406. PubMed ID: 27450875
    [No Abstract]   [Full Text] [Related]  

  • 62. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
    Spiewak M; Malek LA; Misko J; Chojnowska L; Milosz B; Klopotowski M; Petryka J; Dabrowski M; Kepka C; Ruzyllo W
    Eur J Radiol; 2010 Jun; 74(3):e149-53. PubMed ID: 19523780
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis.
    Briasoulis A; Mallikethi-Reddy S; Palla M; Alesh I; Afonso L
    Heart; 2015 Sep; 101(17):1406-11. PubMed ID: 26060120
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
    Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
    Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors.
    Amano Y; Takeda M; Tachi M; Kitamura M; Kumita S
    J Magn Reson Imaging; 2014 Aug; 40(2):407-12. PubMed ID: 24924216
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathy.
    Conte MR; Bongioanni S; Chiribiri A; Leuzzi S; Lardone E; Di Donna P; Pizzuti A; Luceri S; Cesarani F; Mabritto B; Zoccai GB; Bonamini R; Gaita F
    Am Heart J; 2011 Jun; 161(6):1073-7. PubMed ID: 21641353
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.
    Mavrogeni S; Petrou E; Kolovou G; Theodorakis G; Iliodromitis E
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):518-25. PubMed ID: 23324829
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy.
    Efthimiadis GK; Pagourelias ED
    J Am Coll Cardiol; 2009 Dec; 55(1):77. PubMed ID: 20117370
    [No Abstract]   [Full Text] [Related]  

  • 71. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.
    Bogaert J; Olivotto I
    Radiology; 2014 Nov; 273(2):329-48. PubMed ID: 25340269
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Distribution and Clinical Significance of High Signal Intensity of the Myocardium on T2-Weighted Images in 2 Phenotypes of Hypertrophic Cardiomyopathy.
    Amano Y; Aita K; Yamada F; Kitamura M; Kumita S
    J Comput Assist Tomogr; 2015; 39(6):951-5. PubMed ID: 26466104
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Editorial. Hypertrophic Cardiomyopathy with ventricular tachycardia.
    Kwon DH; Desai MY
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):85-7. PubMed ID: 17541762
    [No Abstract]   [Full Text] [Related]  

  • 76. Hypertrophic cardiomyopathy with restrictive phenotype and myocardial crypts.
    Cannavale A; Ordovás KG; Rame EJ; Higgins CB
    J Thorac Imaging; 2010 Nov; 25(4):W121-3. PubMed ID: 20463612
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype.
    Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ
    Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.
    Raman B; Tunnicliffe EM; Chan K; Ariga R; Hundertmark M; Ohuma EO; Sivalokanathan S; Tan YJG; Mahmod M; Hess AT; Karamitsos TD; Selvanayagam J; Jerosch-Herold M; Watkins H; Neubauer S
    Circulation; 2021 Nov; 144(20):1656-1658. PubMed ID: 34780254
    [No Abstract]   [Full Text] [Related]  

  • 79. Apical hypertrophic cardiomyopathy with subendocardial late gadolinium enhancement in an adolescent.
    Boroni Grazioli S; Hitz MP; Voges I
    Cardiol Young; 2021 Feb; 31(2):286-288. PubMed ID: 33377856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hypertrophic cardiomyopathy: A complex disease.
    Young L; Smedira NG; Tower-Rader A; Lever H; Desai MY
    Cleve Clin J Med; 2018 May; 85(5):399-411. PubMed ID: 29733784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.